Critical Survey: Lexicon Pharmaceuticals (NASDAQ:LXRX) and Bristol-Myers Squibb (NYSE:BMY)
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) and Bristol-Myers Squibb (NYSE:BMY – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Insider and Institutional Ownership 74.7% of Lexicon Pharmaceuticals […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) and Bristol-Myers Squibb (NYSE:BMY – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Insider and Institutional Ownership 74.7% of Lexicon Pharmaceuticals […]
